Global and China Oral Proteins and Peptides Market Insights, Forecast to 2027

Global and China Oral Proteins and Peptides Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Oral Proteins and Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type
1.2.2 Linaclotide
1.2.3 Calcitonin
1.2.4 Insulin
1.2.5 Octreotide
1.3 Market by Application
1.3.1 Global Oral Proteins and Peptides Market Size Growth Rate by Application
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Proteins and Peptides Market Size, Estimates and Forecasts
2.1.1 Global Oral Proteins and Peptides Revenue 2016-2027
2.1.2 Global Oral Proteins and Peptides Sales 2016-2027
2.2 Global Oral Proteins and Peptides, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oral Proteins and Peptides Historical Market Size by Region (2016-2021)
2.3.1 Global Oral Proteins and Peptides Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oral Proteins and Peptides Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oral Proteins and Peptides Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oral Proteins and Peptides Sales Forecast by Region (2022-2027)
2.4.2 Global Oral Proteins and Peptides Revenue Forecast by Region (2022-2027)
3 Global Oral Proteins and Peptides Competitor Landscape by Players
3.1 Global Top Oral Proteins and Peptides Manufacturers by Sales
3.1.1 Global Oral Proteins and Peptides Sales by Manufacturer (2016-2021)
3.1.2 Global Oral Proteins and Peptides Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oral Proteins and Peptides Manufacturers by Revenue
3.2.1 Key Oral Proteins and Peptides Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oral Proteins and Peptides Revenue by Manufacturers (2016-2021)
3.2.3 Global Oral Proteins and Peptides Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oral Proteins and Peptides Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oral Proteins and Peptides Revenue in 2020
3.2.6 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oral Proteins and Peptides Price by Manufacturers
3.4 Global Oral Proteins and Peptides Manufacturing Base Distribution, Product Types
3.4.1 Oral Proteins and Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Proteins and Peptides Product Type
3.4.3 Date of International Manufacturers Enter into Oral Proteins and Peptides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oral Proteins and Peptides Market Size by Type (2016-2021)
4.1.1 Global Oral Proteins and Peptides Sales by Type (2016-2021)
4.1.2 Global Oral Proteins and Peptides Revenue by Type (2016-2021)
4.1.3 Oral Proteins and Peptides Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oral Proteins and Peptides Market Size Forecast by Type (2022-2027)
4.2.1 Global Oral Proteins and Peptides Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Proteins and Peptides Revenue Forecast by Type (2022-2027)
4.2.3 Oral Proteins and Peptides Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oral Proteins and Peptides Market Size by Application (2016-2021)
5.1.1 Global Oral Proteins and Peptides Sales by Application (2016-2021)
5.1.2 Global Oral Proteins and Peptides Revenue by Application (2016-2021)
5.1.3 Oral Proteins and Peptides Price by Application (2016-2021)
5.2 Oral Proteins and Peptides Market Size Forecast by Application (2022-2027)
5.2.1 Global Oral Proteins and Peptides Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Proteins and Peptides Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Proteins and Peptides Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Oral Proteins and Peptides Market Size YoY Growth 2016-2027
6.1.1 China Oral Proteins and Peptides Sales YoY Growth 2016-2027
6.1.2 China Oral Proteins and Peptides Revenue YoY Growth 2016-2027
6.1.3 China Oral Proteins and Peptides Market Share in Global Market 2016-2027
6.2 China Oral Proteins and Peptides Market Size by Players (International and Local Players)
6.2.1 China Top Oral Proteins and Peptides Players by Sales (2016-2021)
6.2.2 China Top Oral Proteins and Peptides Players by Revenue (2016-2021)
6.3 China Oral Proteins and Peptides Historic Market Review by Type (2016-2021)
6.3.1 China Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
6.3.2 China Oral Proteins and Peptides Revenue Market Share by Type (2016-2021)
6.3.3 China Oral Proteins and Peptides Price by Type (2016-2021)
6.4 China Oral Proteins and Peptides Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Oral Proteins and Peptides Sales Forecast by Type (2022-2027)
6.4.2 China Oral Proteins and Peptides Revenue Forecast by Type (2022-2027)
6.4.3 China Oral Proteins and Peptides Price Forecast by Type (2022-2027)
6.5 China Oral Proteins and Peptides Historic Market Review by Application (2016-2021)
6.5.1 China Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
6.5.2 China Oral Proteins and Peptides Revenue Market Share by Application (2016-2021)
6.5.3 China Oral Proteins and Peptides Price by Application (2016-2021)
6.6 China Oral Proteins and Peptides Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Oral Proteins and Peptides Sales Forecast by Application (2022-2027)
6.6.2 China Oral Proteins and Peptides Revenue Forecast by Application (2022-2027)
6.6.3 China Oral Proteins and Peptides Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oral Proteins and Peptides Market Size YoY Growth 2016-2027
7.2 North America Oral Proteins and Peptides Market Facts & Figures by Country
7.2.1 North America Oral Proteins and Peptides Sales by Country (2016-2021)
7.2.2 North America Oral Proteins and Peptides Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oral Proteins and Peptides Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Region
8.2.1 Asia Pacific Oral Proteins and Peptides Sales by Region (2016-2021)
8.2.2 Asia Pacific Oral Proteins and Peptides Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oral Proteins and Peptides Market Size YoY Growth 2016-2027
9.2 Europe Oral Proteins and Peptides Market Facts & Figures by Country
9.2.1 Europe Oral Proteins and Peptides Sales by Country (2016-2021)
9.2.2 Europe Oral Proteins and Peptides Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oral Proteins and Peptides Market Size YoY Growth 2016-2027
10.2 Latin America Oral Proteins and Peptides Market Facts & Figures by Country
10.2.1 Latin America Oral Proteins and Peptides Sales by Country (2016-2021)
10.2.2 Latin America Oral Proteins and Peptides Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oral Proteins and Peptides Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country
11.2.1 Middle East and Africa Oral Proteins and Peptides Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Oral Proteins and Peptides Products Offered
12.1.5 Allergan Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Oral Proteins and Peptides Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Biocon
12.3.1 Biocon Corporation Information
12.3.2 Biocon Description and Business Overview
12.3.3 Biocon Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biocon Oral Proteins and Peptides Products Offered
12.3.5 Biocon Recent Development
12.4 Generex Biotechnology
12.4.1 Generex Biotechnology Corporation Information
12.4.2 Generex Biotechnology Description and Business Overview
12.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Generex Biotechnology Oral Proteins and Peptides Products Offered
12.4.5 Generex Biotechnology Recent Development
12.5 Novo Nordisk
12.5.1 Novo Nordisk Corporation Information
12.5.2 Novo Nordisk Description and Business Overview
12.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novo Nordisk Oral Proteins and Peptides Products Offered
12.5.5 Novo Nordisk Recent Development
12.6 Synergy Pharmaceuticals
12.6.1 Synergy Pharmaceuticals Corporation Information
12.6.2 Synergy Pharmaceuticals Description and Business Overview
12.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Synergy Pharmaceuticals Oral Proteins and Peptides Products Offered
12.6.5 Synergy Pharmaceuticals Recent Development
12.7 Tarsa Therapeutics
12.7.1 Tarsa Therapeutics Corporation Information
12.7.2 Tarsa Therapeutics Description and Business Overview
12.7.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Tarsa Therapeutics Oral Proteins and Peptides Products Offered
12.7.5 Tarsa Therapeutics Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Description and Business Overview
12.8.3 Sanofi Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Oral Proteins and Peptides Products Offered
12.8.5 Sanofi Recent Development
12.9 Hoffmann-La Roche
12.9.1 Hoffmann-La Roche Corporation Information
12.9.2 Hoffmann-La Roche Description and Business Overview
12.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hoffmann-La Roche Oral Proteins and Peptides Products Offered
12.9.5 Hoffmann-La Roche Recent Development
12.10 Synthetic Biologics
12.10.1 Synthetic Biologics Corporation Information
12.10.2 Synthetic Biologics Description and Business Overview
12.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Synthetic Biologics Oral Proteins and Peptides Products Offered
12.10.5 Synthetic Biologics Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Oral Proteins and Peptides Products Offered
12.11.5 Allergan Recent Development
12.12 Novartis
12.12.1 Novartis Corporation Information
12.12.2 Novartis Description and Business Overview
12.12.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Novartis Products Offered
12.12.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oral Proteins and Peptides Industry Trends
13.2 Oral Proteins and Peptides Market Drivers
13.3 Oral Proteins and Peptides Market Challenges
13.4 Oral Proteins and Peptides Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Proteins and Peptides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Oral Proteins and Peptides Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Linaclotide
Table 3. Major Manufacturers of Calcitonin
Table 4. Major Manufacturers of Insulin
Table 5. Major Manufacturers of Octreotide
Table 6. Global Oral Proteins and Peptides Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 7. Global Oral Proteins and Peptides Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Oral Proteins and Peptides Sales by Regions (2016-2021) & (K MT)
Table 9. Global Oral Proteins and Peptides Sales Market Share by Regions (2016-2021)
Table 10. Global Oral Proteins and Peptides Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Oral Proteins and Peptides Sales Forecast by Region (2022-2027) & (K MT)
Table 12. Global Oral Proteins and Peptides Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Oral Proteins and Peptides Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Oral Proteins and Peptides Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Oral Proteins and Peptides Sales by Manufacturers (2016-2021) (K MT)
Table 16. Global Oral Proteins and Peptides Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Oral Proteins and Peptides Manufacturers by Revenue (US$ Million) in 2020
Table 18. Oral Proteins and Peptides Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Oral Proteins and Peptides Revenue Share by Manufacturers (2016-2021)
Table 20. Global Oral Proteins and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Proteins and Peptides as of 2020)
Table 22. Key Manufacturers Oral Proteins and Peptides Price (2016-2021) (USD/MT)
Table 23. Oral Proteins and Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oral Proteins and Peptides Product Type
Table 25. Date of International Manufacturers Enter into Oral Proteins and Peptides Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Proteins and Peptides Sales by Type (2016-2021) (K MT)
Table 28. Global Oral Proteins and Peptides Sales Share by Type (2016-2021)
Table 29. Global Oral Proteins and Peptides Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Oral Proteins and Peptides Revenue Share by Type (2016-2021)
Table 31. Oral Proteins and Peptides Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 32. Global Oral Proteins and Peptides Sales Forecast by Type (2022-2027) & (K MT)
Table 33. Global Oral Proteins and Peptides Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Oral Proteins and Peptides Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Oral Proteins and Peptides Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Oral Proteins and Peptides Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 37. Global Oral Proteins and Peptides Sales by Application (2016-2021) (K MT)
Table 38. Global Oral Proteins and Peptides Sales Share by Application (2016-2021)
Table 39. Global Oral Proteins and Peptides Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Oral Proteins and Peptides Revenue Share by Application (2016-2021)
Table 41. Oral Proteins and Peptides Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 42. Global Oral Proteins and Peptides Sales Forecast by Application (2022-2027) & (K MT)
Table 43. Global Oral Proteins and Peptides Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Oral Proteins and Peptides Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Oral Proteins and Peptides Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Oral Proteins and Peptides Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 47. China Oral Proteins and Peptides Sales (K MT) of Key Companies (2016-2021)
Table 48. China Oral Proteins and Peptides Sales Share by Company (2016-2021)
Table 49. China Oral Proteins and Peptides Revenue (US$ Million) by Company (2016-2021)
Table 50. China Oral Proteins and Peptides Revenue Share by Company (2016-2021)
Table 51. China Oral Proteins and Peptides Sales (K MT) by Type (2016-2021)
Table 52. China Oral Proteins and Peptides Sales Share by Type (2016-2021)
Table 53. China Oral Proteins and Peptides Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Oral Proteins and Peptides Price (USD/MT) by Type (2016-2021)
Table 55. China Oral Proteins and Peptides Sales (K MT) by Type (2022-2027)
Table 56. China Oral Proteins and Peptides Sales Share by Type (2022-2027)
Table 57. China Oral Proteins and Peptides Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Oral Proteins and Peptides Revenue Share by Type (2022-2027)
Table 59. China Oral Proteins and Peptides Price (USD/MT) by Type (2022-2027)
Table 60. China Oral Proteins and Peptides Sales (K MT) by Application (2016-2021)
Table 61. China Oral Proteins and Peptides Sales Share by Application (2016-2021)
Table 62. China Oral Proteins and Peptides Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Oral Proteins and Peptides Price (USD/MT) by Application (2016-2021)
Table 64. China Oral Proteins and Peptides Sales (K MT) by Application (2022-2027)
Table 65. China Oral Proteins and Peptides Sales Share by Application (2022-2027)
Table 66. China Oral Proteins and Peptides Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Oral Proteins and Peptides Revenue Share by Application (2022-2027)
Table 68. China Oral Proteins and Peptides Price (USD/MT) by Application (2022-2027)
Table 69. North America Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 70. North America Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 71. North America Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Oral Proteins and Peptides Sales by Region (2016-2021) & (K MT)
Table 74. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Oral Proteins and Peptides Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region (2016-2021)
Table 77. Europe Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 78. Europe Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 79. Europe Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 81. Latin America Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 82. Latin America Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 86. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 89. Allergan Corporation Information
Table 90. Allergan Description and Business Overview
Table 91. Allergan Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 92. Allergan Oral Proteins and Peptides Product
Table 93. Allergan Recent Development
Table 94. AstraZeneca Corporation Information
Table 95. AstraZeneca Description and Business Overview
Table 96. AstraZeneca Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 97. AstraZeneca Product
Table 98. AstraZeneca Recent Development
Table 99. Biocon Corporation Information
Table 100. Biocon Description and Business Overview
Table 101. Biocon Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 102. Biocon Product
Table 103. Biocon Recent Development
Table 104. Generex Biotechnology Corporation Information
Table 105. Generex Biotechnology Description and Business Overview
Table 106. Generex Biotechnology Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 107. Generex Biotechnology Product
Table 108. Generex Biotechnology Recent Development
Table 109. Novo Nordisk Corporation Information
Table 110. Novo Nordisk Description and Business Overview
Table 111. Novo Nordisk Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. Novo Nordisk Product
Table 113. Novo Nordisk Recent Development
Table 114. Synergy Pharmaceuticals Corporation Information
Table 115. Synergy Pharmaceuticals Description and Business Overview
Table 116. Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. Synergy Pharmaceuticals Product
Table 118. Synergy Pharmaceuticals Recent Development
Table 119. Tarsa Therapeutics Corporation Information
Table 120. Tarsa Therapeutics Description and Business Overview
Table 121. Tarsa Therapeutics Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 122. Tarsa Therapeutics Product
Table 123. Tarsa Therapeutics Recent Development
Table 124. Sanofi Corporation Information
Table 125. Sanofi Description and Business Overview
Table 126. Sanofi Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 127. Sanofi Product
Table 128. Sanofi Recent Development
Table 129. Hoffmann-La Roche Corporation Information
Table 130. Hoffmann-La Roche Description and Business Overview
Table 131. Hoffmann-La Roche Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 132. Hoffmann-La Roche Product
Table 133. Hoffmann-La Roche Recent Development
Table 134. Synthetic Biologics Corporation Information
Table 135. Synthetic Biologics Description and Business Overview
Table 136. Synthetic Biologics Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 137. Synthetic Biologics Product
Table 138. Synthetic Biologics Recent Development
Table 139. Hovione Corporation Information
Table 140. Hovione Description and Business Overview
Table 141. Hovione Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 142. Hovione Product
Table 143. Hovione Recent Development
Table 144. Novartis Corporation Information
Table 145. Novartis Description and Business Overview
Table 146. Novartis Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Novartis Product
Table 148. Novartis Recent Development
Table 149. Oral Proteins and Peptides Market Trends
Table 150. Oral Proteins and Peptides Market Drivers
Table 151. Oral Proteins and Peptides Market Challenges
Table 152. Oral Proteins and Peptides Market Restraints
Table 153. Oral Proteins and Peptides Customers List
Table 154. Oral Proteins and Peptides Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Proteins and Peptides Product Picture
Figure 2. Global Oral Proteins and Peptides Sales Market Share by Type in 2020 & 2027
Figure 3. Linaclotide Product Picture
Figure 4. Calcitonin Product Picture
Figure 5. Insulin Product Picture
Figure 6. Octreotide Product Picture
Figure 7. Global Oral Proteins and Peptides Sales Market Share by Application in 2020 & 2027
Figure 8. Gastric & Digestive Disorders
Figure 9. Bone Diseases
Figure 10. Diabetes
Figure 11. Hormonal Disorders
Figure 12. Oral Proteins and Peptides Report Years Considered
Figure 13. Global Oral Proteins and Peptides Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Oral Proteins and Peptides Market Size 2016-2027 (US$ Million)
Figure 15. Global Oral Proteins and Peptides Sales 2016-2027 (K MT)
Figure 16. Global Oral Proteins and Peptides Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Oral Proteins and Peptides Sales Market Share by Region (2016-2021)
Figure 18. Global Oral Proteins and Peptides Sales Market Share by Region in 2020
Figure 19. Global Oral Proteins and Peptides Revenue Market Share by Region (2016-2021)
Figure 20. Global Oral Proteins and Peptides Revenue Market Share by Region in 2020
Figure 21. Global Oral Proteins and Peptides Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Oral Proteins and Peptides Revenue in 2020
Figure 23. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Figure 25. Global Oral Proteins and Peptides Sales Market Share by Type in 2020
Figure 26. Global Oral Proteins and Peptides Revenue Market Share by Type (2016-2021)
Figure 27. Global Oral Proteins and Peptides Revenue Market Share by Type in 2020
Figure 28. Global Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Figure 29. Global Oral Proteins and Peptides Sales Market Share by Application in 2020
Figure 30. Global Oral Proteins and Peptides Revenue Market Share by Application (2016-2021)
Figure 31. Global Oral Proteins and Peptides Revenue Market Share by Application in 2020
Figure 32. China Oral Proteins and Peptides Sales Growth Rate 2016-2027 (K MT)
Figure 33. China Oral Proteins and Peptides Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Oral Proteins and Peptides Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Oral Proteins and Peptides Players Market Share by Revenue in Oral Proteins and Peptides in 2020
Figure 36. China Oral Proteins and Peptides Revenue Share by Type (2016-2021)
Figure 37. China Oral Proteins and Peptides Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Oral Proteins and Peptides Revenue Share by Application (2016-2021)
Figure 39. China Oral Proteins and Peptides Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Oral Proteins and Peptides Sales Growth Rate 2016-2021 (K MT)
Figure 41. North America Oral Proteins and Peptides Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Oral Proteins and Peptides Sales Market Share by Country in 2020
Figure 43. North America Oral Proteins and Peptides Revenue Market Share by Country in 2020
Figure 44. U.S. Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 45. U.S. Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 47. Canada Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Oral Proteins and Peptides Sales Growth Rate 2016-2021 (K MT)
Figure 49. Europe Oral Proteins and Peptides Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Oral Proteins and Peptides Sales Market Share by Country in 2020
Figure 51. Europe Oral Proteins and Peptides Revenue Market Share by Country in 2020
Figure 52. Germany Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 53. Germany Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 55. France Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 57. U.K. Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 59. Italy Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 61. Russia Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Oral Proteins and Peptides Sales Growth Rate 2016-2021 (K MT)
Figure 63. Asia Pacific Oral Proteins and Peptides Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region in 2020
Figure 65. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region in 2020
Figure 66. China Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 67. China Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Oral Proteins and Peptides Sales Growth Rate (2016-2021) (K MT)
Figure 69. Japan Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea O

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs